Disease
Chronic Hepatitis B
Chronic infection with the hepatitis B virus, managed with nucleos(t)ide analogues and finite/curative regimens.
Total attributable cost
$4.4B
$2,609/patient
Drug spend
Not yet sourced
any · US
Disease
Chronic infection with the hepatitis B virus, managed with nucleos(t)ide analogues and finite/curative regimens.
Total attributable cost
$4.4B
$2,609/patient
Drug spend
Not yet sourced
any · US
42 of 42 assets